Question special

Congratulations on a great endeavor and fascinating NEJM paper! I'm looking forward to some stimulating dialogue!

A significant thread running through your paper is the concept of "medical actionability" -- identifying genetic variants which necessitate clinical attention. Can you please tell us a bit about this process of determining what is medically actionable and making this information user-friendly to clinicians?